Company news
Hyloris Pharmaceuticals Sa (EURONEXT:HYL) news
Hyloris Pharmaceuticals Sa news releases on 6ix. Latest, Sep 28, 2026: Consolidated 2026 Half-Year Report: Hyloris Delivers 56% Revenue Growth and Its Lowest…
Press releases & updates
Consolidated 2026 Half-Year Report: Hyloris Delivers 56% Revenue Growth and Its Lowest Half-Year Net Loss Since IPO, Advances Its Mavericks, Core Drivers and Promising Seeds
September 28, 2026
Hyloris Pharmaceuticals : Regulated Information Hyloris’ Annual General Shareholders Meeting on June 9, 2026 ENGLISH VERSION
May 8, 2026
Hyloris Pharmaceuticals : Regulated Information Hyloris releases Annual Report 2025 ENGLISH VERSION
April 30, 2026
Consolidated Results 2025 - Hyloris Achieves Strong Royalty Growth and Portfolio Expansion with Solid Cash Position: a year of bold moves and breakthrough milestones
March 26, 2026
Hyloris Pharmaceuticals : Inside Information Hyloris Provides Update on FDA Review of Valacyclovir for Oral Suspension ENGLISH VERSION
February 19, 2026
Hyloris Pharmaceuticals : Provides Update on FDA Review of Valacyclovir for Oral Suspension
February 19, 2026
Hyloris Pharmaceuticals : Disclosure of a received transparency notification in accordance with article 14 of the act of 2 May 2007 on disclosure of large shareholdings
February 2, 2026
Hyloris Pharmaceuticals : Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets
January 19, 2026
Hyloris Pharmaceuticals : Licenses European and Turkish Rights to Next-Generation Wilson’s Disease Candidate from ArborMed
December 30, 2025
Hyloris Pharmaceuticals : Inside Information Hyloris Announces Partnership with Rosemont Pharmaceuticals for Atomoxetine Oral Solution in the U.S. ENGLISH VERSION
December 29, 2025
Hyloris Pharmaceuticals : Receives Exclusive License Option for Innovative Topical Therapy for a Rare Genetic Skin Disorder
December 11, 2025
Hyloris Pharmaceuticals : Board of Directors appoints Stijn Van Rompay as CEO
November 19, 2025
Hyloris Pharmaceuticals : Announces Positive Clinical Study Results for IV Aspirin
November 14, 2025
Hyloris Pharmaceuticals : Inside Information Hyloris and Orion Partner to Bring Tranexamic Acid RTU to Key European Markets ENGLISH VERSION
October 28, 2025
Hyloris Pharmaceuticals : Announces Partnership with Grand Life Sciences Group for HY-094 in China
October 27, 2025
Consolidated 2025 Half-Year Results and Outlook: Hyloris Achieves Strong Royalty Growth and Portfolio Expansion with Solid Cash Position
September 25, 2025